Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Swedish Orphan Biovitrum (BIOVF) Earnings Date, Estimates & Call Transcripts

Swedish Orphan Biovitrum logo
$47.48 0.00 (0.00%)
As of 05/20/2026

Swedish Orphan Biovitrum Earnings Summary

Swedish Orphan Biovitrum issued Q1 2026 earnings on April 28, 2026, reporting an EPS of $0.45, which topped the consensus estimate of $0.38 by $0.07. Quarterly revenue was reported to be $755.76 million, above the consensus estimate of $749.76 million. With a trailing EPS of $0.30 and a P/E Ratio of 24.60, Swedish Orphan Biovitrum's earnings are expected to grow 54.42% next year, from $2.26 to $3.49 per share.

Q1 2026 Earnings Resources

BIOVF Upcoming Earnings

Swedish Orphan Biovitrum's next earnings date is estimated for Thursday, July 16, 2026, based on past reporting schedules.

Upcoming Q2
Earnings Date
Jul. 16Before Market OpensEstimated
Consensus EPS
(Apr. 28)
$0.38
Actual EPS
(Apr. 28)
$0.45 Beat By $0.07
Actual Revenue
(Apr. 28)
$755.76M
Get Swedish Orphan Biovitrum Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Swedish Orphan Biovitrum and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BIOVF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIOVF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Swedish Orphan Biovitrum Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261$0.39$0.39$0.39
Q3 20261$0.69$0.69$0.69
Q4 20261$0.78$0.78$0.78
2026 3 $1.86 $1.86 $1.86
Q1 20271$0.69$0.69$0.69
Q2 20271$0.66$0.66$0.66
Q3 20271$1.09$1.09$1.09
Q4 20271$1.07$1.07$1.07

Swedish Orphan Biovitrum Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/16/2026
(Estimated)
--------
4/28/2026Q1 2026$0.3821$0.45+$0.0679$0.41$749.76M$755.76M
2/5/2026Q4 2025$0.4567$0.60+$0.1433$0.57$879.40M$846.23M
10/20/2025Q3 2025$0.4925$0.64+$0.1475-$0.87$818.86M$826.53M
7/16/2025Q2 2025$0.18$0.24+$0.06$0.19$644.68M$649.61M
4/29/2025Q1 2025$0.2152$0.26+$0.0448$0.24$644.12M$641.33M
7/16/2024Q2 2024-$0.07-$0.08-$509.05M

Data powered by Fiscal.ai.

Swedish Orphan Biovitrum Earnings - Frequently Asked Questions

Swedish Orphan Biovitrum has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 16th, 2026 based off last year's report dates. Learn more on BIOVF's earnings history.

In the previous quarter, Swedish Orphan Biovitrum (OTCMKTS:BIOVF) reported $0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $0.38 by $0.07. Learn more on analysts' earnings estimate vs. BIOVF's actual earnings.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) has a recorded annual revenue of $2.89 billion.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) has a recorded net income of $48.85 million. BIOVF has generated $0.30 earnings per share over the last four quarters.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) has a trailing price-to-earnings ratio of 24.60 and a forward price-to-earnings ratio of 21.01.

Swedish Orphan Biovitrum's earnings are expected to grow from $2.26 per share to $3.49 per share in the next year, which is a 54.42% increase.


This page (OTCMKTS:BIOVF) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners